© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
Eisuke Fukuma, MD | Authors
Articles
Combination Therapy for Advanced Breast Cancer: Cyclophosphamide, Doxorubicin, UFT, and Tamoxifen
July 01, 1999
We evaluated combination therapy for advanced and recurrent breast cancer with cyclophosphamide (Cytoxan), doxorubicin (Adriamycin), uracil and tegafur (UFT), and tamoxifen (Nolvadex) (CAUT), designed as